The hallmark of CML is the BCR—ABL fusion gene, resulting from a chromosomal abnormality called Ph (Philadelphia chromosome) [4] and implicated in the pathogenesis of the disease. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.